# Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and Treated With High Doses of Radiotherapy (MESORTIBO)

> **NCT06637345** · — · RECRUITING · sponsor: **Centro di Riferimento Oncologico - Aviano** · enrollment: 52 (estimated)

## Conditions studied

- Pleural Mesothelioma Malignant

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06637345
- **Lead sponsor:** Centro di Riferimento Oncologico - Aviano
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-15
- **Primary completion:** 2027-03-15
- **Final completion:** 2027-03-15
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06637345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06637345, "Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and Treated With High Doses of Radiotherapy (MESORTIBO)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06637345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*